Will genome editing replace HSCT for blood diseases?
Genome editing involves the modification of the genome at a specific site in a DNA sequence [1]. Today, genetic engineering is used in overcoming many single-gene ailments such as cystic fibrosis, haemophilia, and a plethora of other diseases. However it was not until 2012, that the genome editing technique known as the Clustered Regularly Interspaced … Read more